T. Rowe Price Associates’s Immatics IMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.42M Sell
652,170
-95,865
-13% -$939K ﹤0.01% 1335
2025
Q4
$7.86M Buy
748,035
+23,228
+3% +$234K ﹤0.01% 1282
2025
Q3
$6.18M Buy
+724,807
New +$4.46M ﹤0.01% 1339
2025
Q1
Sell
-2,461,592
Closed -$17.5M 3055
2024
Q4
$17.5M Sell
2,461,592
-1,032,910
-30% -$8.88M ﹤0.01% 1021
2024
Q3
$39.9M Sell
3,494,502
-145,060
-4% -$1.72M ﹤0.01% 815
2024
Q2
$42.3M Buy
3,639,562
+414,202
+13% +$4.67M 0.01% 769
2024
Q1
$33.9M Buy
3,225,360
+891,191
+38% +$10.4M ﹤0.01% 824
2023
Q4
$24.6M Buy
2,334,169
+719,634
+45% +$6.62M ﹤0.01% 907
2023
Q3
$18.7M Buy
1,614,535
+893,328
+124% +$10.7M ﹤0.01% 931
2023
Q2
$8.32M Buy
721,207
+128,860
+22% +$1.2M ﹤0.01% 1101
2023
Q1
$4.09M Sell
592,347
-26,210
-4% -$215K ﹤0.01% 1233
2022
Q4
$5.39M Buy
618,557
+374,863
+154% +$3.88M ﹤0.01% 1175
2022
Q3
$2.44M Buy
+243,694
New +$2.63M ﹤0.01% 1380

Other funds holding IMTX

T. Rowe Price Associates's IMTX Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Immatics (IMTX) stake by 13% in Q1 2026, selling an estimated $939K and leaving 652,170 shares worth $6.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1335.

T. Rowe Price Associates first reported a position in IMTX in Q3 2022 and has held it in 13 quarters since. The position peaked at $42.3M in Q2 2024. 84 funds tracked by Wall St. Rank hold IMTX as of Q1 2026.

  • T. Rowe Price Associates held 652,170 shares of Immatics worth $6.42M as of Q1 2026.
  • T. Rowe Price Associates sold 95,865 Immatics shares in Q1 2026, an estimated $939K.
  • Immatics made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1335 holding.
  • T. Rowe Price Associates first reported a position in Immatics in Q3 2022 and has held it in 13 quarters since.
  • T. Rowe Price Associates's Immatics position peaked at $42.3M in Q2 2024.
  • 84 funds tracked by Wall St. Rank held Immatics as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.